NuVasive has launched its Reline MAS Midline (RMM), the next evolution of its Reline system designed to provide procedural versatility in a compact midline construct.
The San Diego, CA-based company said the RMM incorporates extremely low-profile modular implants and advanced system instrumentation to address alignment and potentially reduce adjacent segment transition syndrome. The system, when combined with NuVasive access and interbody technologies, is designed to provide a minimally invasive approach to bilateral decompression under complete visualization, interbody fusion, and stabilization with pedicle screws.
Delivering screw modularity, RMM allows for greater procedural flexibility while enhancing visibility and access. RMM tulip pull-off strength is comparable to preassembled pedicle screws, NuVasive noted. Enhanced fixation is achieved with the company's cortical cancellous traction thread form. The system's 5.0mm cobalt chrome construct is low in profile and boasts fatigue strength comparable to 5.5mm titanium.
"RMM posterior fixation represents the most advanced midline cortical pedicle screw system on the market," said minimally invasive spine surgeon Dr. Nitin Khanna, Clinical Faculty of Orthopedic Surgery at the Indiana University School of Medicine and partner at Orthopedic Specialists of Northwest Indiana. "The introduction of modular, low-profile tulip heads was designed to address concerns with adjacent segment facet joint impingement. This system furthers NuVasive's midline portfolio as best-in-class."
The NuVasive RMM solution utilizes adaptable, streamlined instruments to support both cortical and standard trajectory techniques. The midline approach is further simplified with the integration of access, interbody and fixation, while modular screw assembly is confirmed with visual and tactile feedback.
"Innovation is in our DNA and we are constantly looking for ways to take our existing solutions to the next level," said Matt Link, executive vice president, strategy, technology, and corporate development at NuVasive. "RMM, a low-profile midline solution that stands out with its versatility, strength, and reliability, exemplifies our commitment to innovation and provides relevant solutions to meet the diverse and evolving needs of our surgeons worldwide."
The news is consistent with management comments made during the company's first-quarter earnings call in May.
"Innovation remains at the heart of what NuVasive does best and we continue to lead the industry by delivering the technologies and innovations that surgeons want and need," said CEO Greg Lucier during the call, as transcribed by SeekingAlpha.
Lucier said NuVasive plans to launch more than a dozen new products this year spanning from implant systems to the introduction of its Surgical Intelligence platform, as well as next-generation rods for early-onset scoliosis.
"These technologies will help us meet our commitment to enable a complete procedure, enhancing the entire surgical experience and expanding current offerings in key markets," Lucier said.
NuVasive endured a fair amount of challenges in 2017, including significant management turnover and an ugly legal battle with competitor Alphatec. But recent developments suggest this will be a better year for the spine company. Extended product indications, recent acquisitions, and tax benefits have all contributed to a better 2018 for NuVasive, and this latest product launch seems to support that trend.